FREE WEBINAR
Don't rely solely on ELISAs for HCP evaluation in process development
- the 3 reasons why mass spectrometry assays provide better HCP impurity control
Thomas Kofoed
Alphalyse, CEO
I will show the danger of relying solely on ELISA assays for HCP evaluation
(this is the most important reason why so many of our customers use our LC-MS based Host Cell Protein analysis for process development).
You will get examples of how an LC-MS based HCP assay evaluates the difference between batches
– and provides information on which parameters that give specific results.
Bonus: We will go over customer cases
showing how an LC-MS assay was used for documenting the clearance of HCPs during a 6-step purification process, and how info about specific HCPs was used for targeted optimization of the process.